Anticipated Release Date: Q3FY24 OR Q4FY24
Multiple Topics TBD—Possible 3 or 4 The goal of the Therapeutics Capability Area is to develop lead candidate medical treatments and pharmaceuticals that, when administered after exposure to a biological agent or toxin, mitigate or curtail the effects of that exposure and sustain forces operating in a bio- warfare hazard area. Medical Therapeutics encompasses bacterial and viral agent countermeasures as well as biological toxin and neurotoxin countermeasures.
Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end up being right for you, we strongly encourage you to join, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.